The impact of vacuum-assisted excision in the management of indeterminate B3 lesions in the NHS Breast Screening Programme in England

Lee, 2016 Pinder, 2018, NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions), Clin Radiol, 73, 682, 10.1016/j.crad.2018.04.004 Bianchi, 2011, Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy, Breast, 20, 264, 10.1016/j.breast.2010.12.003 Ellis, 2010, Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology, Mod Pathol, 23, S1, 10.1038/modpathol.2010.56 Shaaban, 2019, Management of B3 lesions—practical issues, Curr Breast Cancer Rep, 11, 83, 10.1007/s12609-019-0310-6 NHS Breast Screening Programme Clinical guidance for breast cancer screening assessment, 2016 NHS Breast Screening Programme & Association of breast Surgery Rageth, 2016, First international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions), Breast Cancer Res Treat, 159, 203, 10.1007/s10549-016-3935-4 Rageth, 2019, Second international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions), Breast Cancer Res Treat, 174, 279, 10.1007/s10549-018-05071-1 Forester, 2019, High risk (B3) breast lesions: what is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis, Eur J Surg Oncol, 45, 519, 10.1016/j.ejso.2018.12.008 Mayer, 2017, Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy, Breast, 31, 144, 10.1016/j.breast.2016.11.007 Hoffmann, 2016, B3-lesions of the breast and cancer risk-an analysis of mammography screening patients, Mol Clin Oncol, 4, 705, 10.3892/mco.2016.790 Rajan, 2011, What is the significance of flat epithelial atypia and what are the management implications?, J Clin Pathol, 64, 1001, 10.1136/jclinpath-2011-200176 Rudin, 2017, Flat epithelial atypia on core biopsy and upgrade to cancer: a systematic review and meta-analysis, Ann Surg Oncol, 24, 3549, 10.1245/s10434-017-6059-0 Lamb, 2017, Flat epithelial atypia: upgrade rates and risk-stratification approach to support informed decision making, J Am Coll Surg, 225, 696, 10.1016/j.jamcollsurg.2017.08.022 Badan, 2016, Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution, Radiol Bras, 49, 6, 10.1590/0100-3984.2014.0110 Khoury, 2016, The risk of upgrade for atypical ductal hyperplasia detected on magnetic resonance imaging-guided biopsy: a study of 100 cases from four academic institutions, Histopathology, 68, 713, 10.1111/his.12811 Latronico, 2018, Atypical ductal hyperplasia: our experience in the management and long term clinical follow-up in 71 patients, Breast, 37, 1, 10.1016/j.breast.2017.10.003